# FDA 483 - Krystal Biotech, Inc. - November 16, 2022

Source: https://www.globalkeysolutions.net/records/483/krystal-biotech-inc/bc54c53c-606d-4637-b5cc-115b3eb0c9e7

> FDA 483 for Krystal Biotech, Inc. on November 16, 2022. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Krystal Biotech, Inc.
- Inspection Date: 2022-11-16
- Product Type: biologics
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Documents

- [483 - 2025-01-30](https://www.globalkeysolutions.net/records/483/krystal-biotech-inc/53e24ecb-963d-4403-8a81-eb55c7fe637c)
- [483 - 2025-01-30](https://www.globalkeysolutions.net/records/483/krystal-biotech-inc/28135d70-5edc-40a1-8bc2-3ebb58abf828)
- [483 - 2025-01-30](https://www.globalkeysolutions.net/records/483/krystal-biotech-inc/6052640f-1207-4f00-b797-0b772a72f82f)
- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/krystal-biotech-inc/9eb41273-b9f1-4b8b-99c1-e0e7ef5bf59d)

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/priscilla-m-pastrana/170080d1-49da-42d7-8615-c774cac9f7ec)
- [Jianyang Wang](https://www.globalkeysolutions.net/people/jianyang-wang/92951156-d0f6-4100-b22c-ae2d03683773)
- [investigator](https://www.globalkeysolutions.net/people/wei-wang/943039ac-3917-4d32-9f58-1886c56aecdd)
- [Bo Liang](https://www.globalkeysolutions.net/people/bo-liang/9902f822-7544-4e11-8cdc-49a99627db13)
- [Carl A. Perez](https://www.globalkeysolutions.net/people/carl-a-perez/a7214b90-7632-4aff-8afb-33f1d7e7917d)

Company: https://www.globalkeysolutions.net/companies/krystal-biotech-inc/a9722688-fbec-493a-b344-89b3fb41b9ab

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd